| Name | Title | Contact Details |
|---|
Lifeblood opens the East Donor Center on Estate Drive. In 1954, another proposal to establish a blood center in Memphis was rejected for the same reason-it was too costly. Finally in 1962, the Committee on Blood Bank Operation of the Memphis and Shelby
Scarborough Community Care Access Centre is a Scarborough, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
To enhance the health and well being of our communities through the compassionate delivery of quality healthcare. An organization of caring professionals trusted as our community’s healthcare system of choice for clinical excellence.
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
Brave Health is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.